NCT03740529 2026-01-27A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLEli Lilly and CompanyPhase 1/2 Completed803 enrolled 2 FDA
NCT03997968 2024-12-24A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid TumorsCyteir Therapeutics, Inc.Phase 1/2 Completed169 enrolled
NCT00867529 2018-01-02Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell LymphomaFred Hutchinson Cancer CenterPhase 2 Completed63 enrolled 12 charts
NCT00617929 2017-12-28Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantMasonic Cancer Center, University of MinnesotaPhase 2 Terminated12 enrolled 12 charts
NCT01118845 2013-07-04Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell LymphomaSymBio PharmaceuticalsPhase 2 Completed63 enrolled 46 charts